Laponis Adam 4
4 · Twist Bioscience Corp · Filed Feb 25, 2026
Insider Transaction Report
Form 4
Laponis Adam
Chief Financial Officer
Transactions
- Sale
Common Stock
[F1][F2]2026-02-23$46.71/sh−2,085$97,390→ 128,291 total
Footnotes (2)
- [F1]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
- [F2]Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Signature
/s/ Kendra Fox, as Attorney-in-Fact for Adam Laponis|2026-02-25